Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for TEVA-SUCRALFATE

Brand name

TEVA-SUCRALFATE

Company Name

TEVA CANADA LIMITED

Drug Identification Number

02045702

Ingredients & Strength

SUCRALFATE (1 G)

Anatomical Therapeutical Chemical (ATC) Code

A02BX
A02BX

Anatomical Therapeutical Chemical (ATC) Descriptor

DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)

Status

MARKETED

Shortage reports
Brand name	Packaging size	Status	Date Created	Date Updated	Reports
TEVA-SUCRALFATE	500	Resolved	2019-08-29	2020-01-30	92663
TEVA-SUCRALFATE	100	Resolved	2020-03-26	2020-08-21	109595
TEVA-SUCRALFATE	500	Resolved	2020-07-23	2020-08-21	120890
TEVA-SUCRALFATE	500	Resolved	2020-09-24	2020-10-15	124995
TEVA-SUCRALFATE	500	Resolved	2021-04-01	2021-04-08	136759
TEVA-SUCRALFATE	500	Resolved	2021-04-29	2021-05-13	138300
TEVA-SUCRALFATE	500	Resolved	2021-06-17	2021-07-22	141113
TEVA-SUCRALFATE	100	Resolved	2021-08-27	2021-09-30	144760
TEVA-SUCRALFATE	500	Resolved	2021-09-30	2021-11-05	146469
TEVA-SUCRALFATE	100	Resolved	2021-10-07	2021-11-05	146856

1
2
3
Next

Showing 1 to 10 of 23

Discontinuation reports
Brand name	Packaging size	Status	Date Created	Date Updated	Reports
TEVA-SUCRALFATE	ALL (100's and 500's)	Discontinued	2025-09-02	2025-09-02	266359

1

Showing 1 to 1 of 1